Question 3: Did the recipient receive a subsequent infusion?
Indicate if the recipient received a subsequent infusion during the reporting period. Subsequent infusions include transplant, cellular therapy, gene therapy, DLI, and ‘boost’ (autologous or allogeneic).
If Yes, complete the Indication for CIBMTR Data Reporting (2814).
For more information on infusion types, review Appendix D: How to Distinguish Infusion Types.
Section Updates:
| Question Number | Date of Change | Add/Remove/Modify | Description | Reasoning (If applicable) |
|---|---|---|---|---|
| . | . | . | . | . |
Last modified:
Jul 29, 2024
Need more help with this?
Don’t hesitate to contact us here.